Organon Teknika signs distribution deal with Toyobo:
This article was originally published in Clinica
Executive Summary
Organon Teknika has signed a sub-licensing agreement with Toyobo, granting the Japanese company non-exclusive rights to market Cangene's NASBA technology. The deal will cover infectious disease screening, and cancer and genetic testing in Japan. Cangene was recently granted a US patent for NASBA, covering RNA amplification and a European patent in June 1994 (see Clinica No 609, p 16). Organon is a partner of Cangene (Canada) and a subsidiary of Dutch company Akzo Nobel.